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Preventive strategies of renal failure in the Arab world. The
prevalence of both acute and chronic renal failure is high in
the Arab world. Data available on the exact prevalence of var-
ious renal diseases are very limited. Nevertheless, the reported
prevalence of chronic renal failure is 80 to 120 per million pop-
ulation (pmp) in the Kingdom of Saudi Arabia and 225 pmp
in Egypt. This is in comparison with the reported prevalence
of 283 pmp in Europe, 975 pmp in the United States, and 1149
pmp in Japan. Lower prevalence rates reported in this region
could be due to underreporting.
The economic burden of renal replacement on health care
providers is enormous. In the Kingdom of Saudi Arabia, the esti-
mated cost per annum incurred toward maintenance hemodial-
ysis is US $19,400 and, considering that there are more than
7200 patients on regular dialysis in this country, the total ex-
penditure is enormous. Such large amounts may be beyond the
monetary capacity of many countries in this region because of
limited financial resources.
These figures clearly suggest that there is an urgent need to
establish a massive prevention program. The strategy adapted
should be innovative and imaginative and should be one that is
maximally cost effective.
Paradoxically, in the Arab world, we have a good opportunity
to reduce the incidence of kidney failure (chronic and acute)
substantially by appropriately chosen models. This is because
many of the causes of renal failure are eminently preventable.
In fact, a rough estimate is that these programs, if successful, can
reduce the incidence by as much as 40% (personal communica-
tion, Shaheen, 2003). It is worthy of mention that, in the Arab
world, the budget for research is about 0.15% of the national
domestic product compared with the international average of
1.5%.
In this article, we concentrate on some of the main causes of
renal failure in the Arab world that we feel can be prevented
and suggest ways that can best address this issue.
SOME COMMON RENAL PROBLEMS SEEN IN
THE ARAB WORLD
Diabetes mellitus
Diabetes mellitus is a very common cause of end-stage
renal disease (ESRD) in the Arab world. In Saudi Ara-
bia, the prevalence is estimated to be 25% and the inci-
dence 45% [1]. Similar high prevalence rates have been
reported from a number of Arab countries. For example,
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rates were found to be 46.8% in Lebanon [2], 21.2% in
Kuwait [3], and 35% in Egypt [4].
Obesity is known to predispose to insulin resistance
and diabetes. The reported prevalence of obesity among
school children in Riyadh, the capital city of the King-
dom of Saudi Arabia (KSA) is reaching 18% [5]. Similar
high prevalence rates are expected to be found in other
countries of the region that have social and cultural back-
grounds in common. According to a report published in
1999, at least one third of the Arab population can be
categorized as obese [6].
There is a great opportunity to reduce obesity through
appropriate campaigns. It has been shown that lifestyle
modification can cause a decrease in the number of per-
sons that potentially develop diabetes mellitus. This oc-
curs mainly because of weight reduction. We believe that
an intensive campaign supported by the media, as well as
an obligatory training and sports program established by
the ministries of education at school, would have a very
positive result. With such a program, it is expected that
there would be a reduction in the number of individuals
that develop diabetes mellitus which, in turn, would re-
duce the number of persons requiring dialysis in the long
run.
Although the use of angiotensin-converting enzyme in-
hibitors (ACEI) and angiotensin receptor blockers has
proved to be beneficial in slowing the rate of worsen-
ing renal failure, these drugs are prohibitively expensive
for use in all patients with early diabetes. Thus, a dedi-
cated campaign aimed at primary care physicians about
proper glycemic and blood pressure control and selective
use of ACEI and ARBs in patients with diabetes, espe-
cially when microalbuminria ensues, will bear very pal-
pable results. Early screening and referral hold the key
to a successful prevention program.
HYPERTENSIVE RENAL DISEASE
Not many studies on hypertension are available from
the region. A report from Egypt estimated that the preva-
lence of hypertension in that country was 26.3% [7] in
comparison with 24% reported from the United States
[8]. Extrapolating from this data, one can say that hyper-
tension is widely prevalent in the Arab world. Whether
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the Arab patient with hypertension behaves more like
the African American or Caucasian with hypertension is
unknown. This is an area of research that renal physicians
in the Arab world should pursue, because it will have a
direct impact on prevention policies. Screening clinics,
primary care physician education, and public awareness
will be useful here.
ACUTE RENAL FAILURE
The majority of the causes of acute renal failure that
is seen in Arab countries are preventable. Main culprits
include malaria [9] and renal stones. (In Sudan, 12% of
ESRD is due to renal calculi.) [10] A number of reports
indicate that hair dye ingestion [11] is a prominent cause
of acute renal failure. Public education, with regards to
ingestion of such substances, is warranted. Aggressive
campaigns to eradicate malaria need close attention from
governments of countries in which malaria is common.
CHRONIC INTERSTITIAL NEPHRITIS
Although exact prevalence rates are not available from
the region, it is believed that chronic interstitial nephritis
is a common problem in Arab countries. Apart from re-
nal stones as a cause, analgesic nephropathy and disease
caused by other over-the-counter drug abuse is possibly to
blame. Another important cause is the widespread use of
herbal medicines whose benefits and/or toxicity profiles
have not been verified. These are compounded by the ma-
jor problem of buying virtually any drug from the phar-
macy without a doctor’s prescription. Although bylaws
exist against this practice, they are not enforced properly.
OBSTRUCTIVE UROPATHY
In many Arab countries, obstructive uropathy con-
stitutes a major cause (40%) of ESRD [12]. The two
most common underlying causes are renal calculi [10]
and schistosomiasis [7]. Reports on the nature of renal
caculi in Arab countries are limited. In the few reports
available, the common makeup of the stones is either
urates or calcium oxalates [13]. It is quite likely that the
hot and humid climate is a primary reason for the high
prevalence of calculi. Also, people may not drink as much
fluid as they ought to. Highly concentrated, small-volume,
24-hour urine output has been found in otherwise nor-
mal kidney donors [14]. Early referral of stone formers
and eradication of schistosomiasis are crucial here. Cam-
paigns in the media and at schools encouraging the intake
of up to 3 liters of water per day in healthy adults should
be mandated.
Schistosomiasis is a very common disease in a num-
ber of Arab countries [7]. Both mansoni and hemoto-
bium types are present. In fact, the common prevalence of
bladder cancer and liver disease in these countries can be
explained on the basis of these parasites, respectively. Ob-
structive uropathy in these patients results largely from
the development of ureteric fibrosis as well as “shrunken”
bladders. It is mandatory for physicians in our region to
do an ultrasound of the kidney whenever faced with a
case of renal failure to exclude obstruction. If present, it
should be addressed quickly by dilatation, stenting, ex-
tracorporeal shock wave lithotripsy, drainage, or surgery,
depending on the findings.
Besides eradication of schistosomiasis, rural health ed-
ucators should be in place to advise children against play-
ing and swimming in stagnant ponds and dirty water. Ru-
ral areas should be provided with therapy against schis-
tosomiasis when and if required.
Obstructive uropathy is a major source of renal mor-
bidity, and attention to prevention in this area will yield
considerable reduction in the prevalence of renal failure.
HEPATITIS B AND C
Hepatic viruses are common in the region, with vari-
able prevalence between and within the same country.
The prevalence of hepatitis B virus (HBV) in the gen-
eral population is 6.7% in KSA [15], 4% in Egypt, and
10% in Jordan [16]. This is much higher than what has
been reported in Western countries, in which prevalence
varies between 0.2% and 2% [17, 18]. The clear impact
of vaccinating against HBV on its prevalence is clear to
see in KSA, where prevalence has dropped from 10% to
12% in the early 1980s to 6% at the end of the last cen-
tury. To make sure that all parents bring their children to
be vaccinated, the government in KSA does not issue a
birth certificate until all necessary vaccinations are given.
Similar policies should be pursued by other Arab coun-
tries. Women married to HBV-positive husbands should
be immunized to prevent sexual transmission and vertical
transmission in the long run. A number of generic formu-
lations of this vaccination are available in the market at
a fraction of the cost of the original.
Similarly, HCV is more common in Arab countries than
in the West, with 1.8% in KSA, 2.1% in Jordan, and
0.7% in Tunisia [19]. In Egypt, the prevalence is strik-
ingly high, with 18.1% reported in the general popula-
tion [19]. Although there is no vaccination against HCV
so far, its incidence, and therefore the incidence of the as-
sociated glomerulonephritis, can be greatly reduced by:
public education, governmental monitoring, control of
needles used for injections and blades used in barber
shops, and education to high-risk groups on the impor-
tance of washing and using barrier techniques. In many
Arab countries, the practice of “cupping” for blood ex-
traction is used widely as a form of traditional therapy.
Again, this should be monitored and controlled.
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It would also be extremely useful to start the practice
of premarital testing, which is happening in Saudi Arabia.
Therefore, if a potential spouse is found to be positive for
HBV, his/her partner spouse will be vaccinated, if he/she
is not already immune.
TUBERCULOSIS
Tuberculosis is quite common, especially in certain
Arab countries, with a prevalence rate of >15 per 100,000
persons according to the World Health Organization. It is
noteworthy that the prevalence of renal failure in a given
country correlates well with the prevalence of tubercu-
losis. This could simply be related to the low standard of
living, although it is well established that tuberculosis can
cause renal failure by at least 3 mechanisms: (1) Fibrosis/
stricture of the urinary system leading to obstructive
uropathy. This may be associated with calcification and
nonfunction of the kidney (autonephroctemy); (2) The
development of immune-complex glomerulonephritis;
(3) The development of renal amyloidosis.
In fact, the most common cause of renal amylodosis
discovered by renal biopsy in Arab countries is tuber-
culosis. It would therefore be expected that eradication,
or at least the reduction of the number of cases of tu-
berculosis, would be associated with reduction in renal
failure. Unfortunately, this is not happening and, indeed,
the incidence of tuberculosis is rising. An intensive cam-
paign of vaccination, screening, and isolation of open
cases is required. This could be costly but is well worth it.
Many poor Arab countries can get the help of the World
Health Organization and World Bank for eradication
programs.
NONCOMPLIANCE
There is a major loss of transplanted kidneys due to
noncompliance and improper follow-up as well as use
of expensive immunosuppressive drugs, which Arab pa-
tients may not be able to buy. Physicians that perform
transplants could improve in this area (of noncompli-
ance) by a number of practical and achievable measures
such as: (1) The use of cheaper immunosuppressive drugs
such as azathiaprine and/or the use of drugs that can
raise the blood level of cyclosporine such as erythromycin
or ketoconazole. Alternatively, expensive but powerful
drugs such as cyclosporine, tacrlomus, mycophenolate
mofetil, and sirolimus could be used for only a short
period immediately after transplantation to be replaced
by cheaper drugs after 3 to 6 months after the trans-
plant operation. (2) Arranging for follow-up to be car-
ried out near the patient’s home. Currently, patients
have to travel long distances to visit centers for post-
transplant follow-up. This is bound to encourage non-
compliance. Instead, transplant centers should impart
intensive training of “local” doctors who, in turn, can
undertake the duty of routine follow-up. Alternatively,
major centers could send their staff periodically to var-
ious areas to review patients closer to their homes. It is
worth negotiating, with relevant pharmaceutical compa-
nies, the possibility of funding transport costs of such ar-
rangements.
INHERITED AND CONGENITAL KIDNEY
DISEASES
The incidence and prevalence of preventable inher-
ited diseases leading to renal diseases are palpably more
common in the Arab world than other regions [20].
This is often related to the high degree of consanguin-
ity [20]. In some Arab countries, first-cousin marriages
constitute 52% of all marriages taking place. For exam-
ple, primary hyperoxaluria (which is the cause of ESRD
in 13.5% of Tunisian children) [13], reflux nephropathy
(which accounts for 53% of ESRD in Libyan children),
hydronephrosis, which is discovered during pregnancy,
hypoplastic kidneys, urethral valves, and sickle cell dis-
ease [21] have all been found to be major causes of kidney
disease and renal failure in the Arab world. Congenital
kidney diseases occur in 3.3 per 1000 births (80% of which
are due to hydronephrosis).
There are potentially reversible causes, such as: (1) Pre-
ventive measures through early diagnosis with prenatal,
perinatal, or neonatal ultrasound of the urinary system.
This may be expensive to perform in certain countries but
has the clear advantage of having no risk and being readily
repeatable. (2) Preventive measures by public education;
and (3) Preventive measures by genetic counseling and
premarital screening.
MEDIA CONTRIBUTION
There are over 30 satellite channels in Arabic, the ma-
jority of which reach all Arab countries and can be seen
free of cost. The Arab public is fond of following medi-
cal news and calls frequently to live television shows dis-
cussing medical issues. This medium has not been used
to any significant degree. It ought to be used for ed-
ucational purposes in matters having to do with pre-
vention of renal diseases in a simplified and interesting
format. Special attention should be given to prevention of
diabetic, hypertensive, and genetic renal diseases. The im-
portance of seeking medical advice symptoms of renal
nature appear, especially those that may suggest renal
calculi, should be stressed. The danger of using anal-
gesics, nonsteroidal, antiinflammatory drugs, and other
nonprescription drugs should be highlighted as well as
the need for perhaps yearly measurement of one’s blood
pressure.
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With the help of Professor Kim Solez, we have estab-
lished a public kidney education web site in Arabic called
“Tawasol.”
STANDARD OF LIVING
As the standard of living improves, so do the standards
of health and hygiene. This, in turn, is expected to be as-
sociated with a reasonable reduction in the prevalence
of kidney failure. This is not surprising, because one of
the common causes of ESRD, in many series, is immune-
complex glomeulonephritis which, in many instances, is
secondary to infections. This is clearly illustrated by the
remarkable drop of poststreptococcal glomerulonephri-
tis in Britain around the turn of the 19th century, as the in-
dustrial revolution led to employment opportunities and
improved the incomes of workers.
It is not possible to improve living standards of a nation
by the stroke of a pen, but it is not impossible with proper
economic planning. One would hope that Arab countries
could immolate the path taken by such countries as South
Korea or Malaysia, which managed to do just that over a
mere decade or two.
SUMMARY AND CONCLUSION
Although kidney diseases are common in Arab coun-
tries, the opportunity for prevention is immense through:
the use of media for public education; campaign of
lifestyle changes to reduce diabetes mellitus; eradication
programs against malaria and schistosomiasis; early refer-
ral and detection for renal stones; prevention and treat-
ment of infants’ dehydration; mobile screening clinics
for hypertension; prenatal/postnatal screening for renal
anomalies; genetic premarital counseling; pretransplant
patient education and proper follow-up; strict application
of not allowing drugs to be obtained from pharmacies
without a doctor’s prescription.
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